Connective Tissue-Activating Peptide III: A Novel Blood Biomarker for Early Lung Cancer Detection
AUTOR(ES)
Yee, John
FONTE
American Society of Clinical Oncology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2698017Documentos Relacionados
- Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III.
- Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor.
- Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification
- Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis
- Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer